Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 3, 2002, Pages 609-611

  Vaiva, Guillaume ^a   De Chouly De Lenclave, Marie Bérengère ^a   Bailly, Daniel ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Attention deficit hyperactivity disorder; Drug dependence; Moclobemide; Monoamine oxidase A

Indexed keywords

CANNABIS; CLONIDINE; DIAMORPHINE; MOCLOBEMIDE; OPIATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG WITHDRAWAL; FAMILY HISTORY; HUMAN; MALE; OPIATE ADDICTION; TREATMENT OUTCOME;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MALE; MOCLOBEMIDE; OPIOID-RELATED DISORDERS;

EID: 0036197152     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00259-7     Document Type: Article

References (29)

1. Administration of moclobemide in children with attention-deficit hyperactivity disorder
2. Comorbidity of substance abuse and other psychiatric disorders in adolescents
3. Psychiatric illness in the families of hyperactive children
4. Treatment of the attention deficit disorder (residual type) with moclobemidem
5. Cocaine abuse and adult attention deficit disorder
6. A teacher rating scale for use in drug studies with children
7. Rating scales and checklists for child psychopharmacology
8. Symptomatic volunteers in multicenter drug trials
9. Selegiline in adults with attention deficit/hyperactivity disorder: Clinical efficacy and safety
10. Selegiline in ADHD adults: Plasma monoamines and monoamine metabolites
11. Prevalence of drug treatment for hyperactivity and other childhood behavior disorders
12. Clinical implications of the relationship between attention deficit hyperactivity disorder and psychoactive substance use disorders
13. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence
14. The importance of childhood hyperactivity in the development of substance use disorders
15. Cellular and molecular mechanisms of drug dependence
16. Follow-ups of children with attention deficit hyperactivity disorder (ADHD). Review of literature
17. A two-part model of stimulant action on attention deficit hyperactivity disorder in children
18. A new depression scale designed to be sensitive to change
19. A family study of the hyperactive child syndrome
20. Ambulatory opiate detoxification and primary care: A role for the primary care physician
21. Monoamine oxidase inhibitors in the treatment of attention deficit disorder - Residual type. A case report
22. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives
23. Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity
24. Differentiation of alcoholics according to childhood history of minimal brain dysfunction, family history, and drinking patterns
25. Use of moclobemide in children with attention deficit hyperactivity disorder
26. Attention deficit hyperactivity disorder. Adult manifestations
27. Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders
28. Treatment of hyperactive children with monoamine oxidase inhibitors: I. Clinical efficacy